Biomedical engineering researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a technique that uses a patch embedded with microneedles to deliver cancer immunotherapy ...
Bio & Medicine
Mar 24, 2016
0
55
Using a gene-editing system originally developed to delete specific genes, MIT researchers have now shown that they can reliably turn on any gene of their choosing in living cells.
Biotechnology
Dec 10, 2014
1
0
A protein implicated in several cancers appears to play a pivotal role in keeping stem cells in an immature "pluripotent" state, according to a new study by NYU Langone Medical Center scientists. The study is published online ...
Cell & Microbiology
Sep 25, 2014
0
0
Since the completion of the Human Genome Project, which identified nearly 20,000 protein-coding genes, scientists have been trying to decipher the roles of those genes. A new approach developed at MIT, the Broad Institute, ...
Biotechnology
Dec 12, 2013
0
0
(Phys.org) —Activating the body's immune system to attack cancer and prevent it from recurring is one of the Holy Grails of cancer research because of its ability to specifically target cancer and to search almost anywhere ...
Bio & Medicine
Jul 15, 2013
0
0
Scientists at Washington University School of Medicine in St. Louis and elsewhere have decoded the genome of the platyfish, a cousin of the guppy and a popular choice for home aquariums. Among scientists, the fish are meticulously ...
Biotechnology
Apr 15, 2013
1
0
(Phys.org)—Malignant melanoma is the most aggressive type of skin cancer. In more than 50 percent of affected patients a particular mutation plays an important role. As the life span of the patients carrying the mutation ...
Bio & Medicine
Feb 15, 2013
0
0
Red coloration—historically seen as costly in vertebrates—historically seen as costly in vertebrates—might represent some physiological benefit after all, according to research published in the journal Physiological ...
Plants & Animals
Jan 28, 2013
6
0
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Bio & Medicine
Jun 13, 2011
1
1
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's lymphoma, chronic ...
Biotechnology
Mar 2, 2011
0
0
